Article
Study of drug resistance-associated genetic mutations, and phylo-genetic analysis of HCV in the Province of Sindh, Pakistan.
Scientific reports - 27 Jul 2023
Faiz Sirmast, Irfan Muhammad, Farooq Saba, Khan Ishtiaq Ahmad, Iqbal Hana'a, Wahab Atia-Tul, Shakeel Muhammad, Gong Peng, Iftner Thomas, Choudhary M Iqbal
Abstract excerpt
Current management of HCV infection is based on Direct-Acting Antiviral Drugs (DAAs). However, resistance-associated mutations, especially in the NS3 and NS5B regions are gradually decreasing the efficacy of DAAs. The aim of the current study was to identify such mutations in the NS3, and NS5B genes in DAAs treatment-naïve Pakistani chronic HCV 3a patients. Peripheral blood samples were collected from 233 chronic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
